Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Suneeta Tumati"'
Autor:
Todd W. Vanderah, Tally M. Largent-Milnes, Eva V. Varga, Takashi Yamamoto, Victor J. Hruby, Attila Keresztes, Suneeta Tumati, William R. Roeske
Publikováno v:
European Journal of Pharmacology. 684:64-70
Prolonged morphine treatment increases pain sensitivity in many patients. Enhanced spinal Substance P release is one of the adaptive changes associated with sustained opioid exposure. In addition to pain transmitting second order neurons, spinal micr
Publikováno v:
European Journal of Pharmacology. 648:95-101
Tissue damage leads to pain sensitization due to peripheral and central release of excitatory mediators such as prostaglandin E 2 (PGE 2 ). PGE 2 sensitizes spinal pain neurotransmitter such as calcitonin gene-related peptide (CGRP) release via activ
Autor:
Tally M. Largent-Milnes, Eva V. Varga, Todd W. Vanderah, R Wang, William R. Roeske, Suneeta Tumati
Publikováno v:
British Journal of Pharmacology. 161:51-64
BACKGROUND AND PURPOSE Long-term morphine treatment enhances pain neurotransmitter [such as calcitonin gene-related peptide (CGRP)] levels in the spinal cord. It has been suggested previously that increased spinal CGRP may contribute to sustained mor
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 330:810-817
Studies have shown that long-term (5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol (morphine) treatment increases the sensitivity to painful heat stimuli (thermal hyperalgesia). The cellular adaptations contributing to sustained morphine
Publikováno v:
Analytical Biochemistry. 387:95-101
A procedure has been developed for directly depositing membrane fragments derived from bacterial cells (chromatophores from Rhodopseudomonas sphaeroides) and mammalian cells (μ-opioid receptor- and MC4 receptor-transfected human embryonic kidney (HE
Autor:
Zdzislaw Salamon, Isabel D. Alves, Gordon Tollin, Suneeta Tumati, Teodora Georgieva, William R. Roeske, Henry I. Yamamura, Eva V. Varga
Publikováno v:
Current Molecular Pharmacology. 1:273-284
Cannabinoid (CB) agonists exhibit numerous potentially useful pharmacological properties, but unwanted side effects limit their use in clinical practice. Thus, novel strategies are needed to identify potential CB pharmaceuticals with fewer side effec
Autor:
Josephine Lai, Todd W. Vanderah, Peg Davis, Sharif Moye, Tally M. Largent-Milnes, Padma Nair, Henry I. Yamamura, Takashi Yamamoto, Edita Navratilova, Shou Wu Ma, Josef Vagner, Victor J. Hruby, Suneeta Tumati, Frank Porreca
Publikováno v:
Journal of Medicinal Chemistry. 51:1369-1376
A series of bifunctional peptides with opioid agonist and substance P antagonist bioactivities were designed with the concept of overlapping pharmacophores. In this concept, the bifunctional peptides were expected to interact with each receptor separ
Autor:
Suneeta, Tumati, Tally M, Largent-Milnes, Attila I, Keresztes, Takashi, Yamamoto, Todd W, Vanderah, William R, Roeske, Victor J, Hruby, Eva V, Varga
Publikováno v:
European journal of pharmacology. 684(1-3)
Prolonged morphine treatment increases pain sensitivity in many patients. Enhanced spinal Substance P release is one of the adaptive changes associated with sustained opioid exposure. In addition to pain transmitting second order neurons, spinal micr
Autor:
Tally M. Largent-Milnes, Jiyang Ren, Todd W. Vanderah, William R. Roeske, Eva V. Varga, Attila Keresztes, Suneeta Tumati
Publikováno v:
Journal of neuroimmunology. 244(1-2)
Spinal glial activation has been implicated in sustained morphine-mediated paradoxical pain sensitization. Since activation of glial CB2 cannabinoid receptors attenuates spinal glial activation in neuropathies, we hypothesized that CB2 agonists may a
Autor:
Frank Porreca, Steven Ballet, Jozef Vanden Broeck, Koen Buysse, Attila Keresztes, Nga N. Chung, Josephine Lai, Eva V. Varga, Peter W. Schiller, Suneeta Tumati, Carole Lemieux, Dirk Tourwé, Debby Feytens, Joost Van Duppen
Publikováno v:
Journal of medicinal chemistry. 54(7)
A screening of conformationally constrained aromatic amino acids as base cores for the preparation of new NK1 receptor antagonists resulted in the discovery of three new NK1 receptor antagonists, 19 [Ac-Aba-Gly-NH-3',5'-(CF(3))(2)-Bn], 20 [Ac-Aba-Gly